Original ArticlesThe pharmacokinetics of idraparinux, a long-acting indirect factor Xa inhibitor: population pharmacokinetic analysis from Phase III clinical trials
Under an Elsevier user license
open archive
Keywords
atrial fibrillation
idraparinux
population pharmacokinetics
stroke
venous thromboembolism
Cited by (0)
Copyright © 2009 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.